APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Alitretinoin Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alitretinoin Drugs Market Outlook and Growth Opportunities 2026

29 December 2025190 pages

Choose your research edition.

Industry ResearchAlitretinoin Drugs Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Alitretinoin Drugs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Alitretinoin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alitretinoin Drugs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Alitretinoin Drugs Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Alitretinoin Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alitretinoin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alitretinoin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alitretinoin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alitretinoin Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alitretinoin Drugs market include Eisai, Stiefel Laboratories, GlaxoSmithKline, Ligand Pharmaceuticals, Dr. Reddy's Laboratories and Amdipharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alitretinoin Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alitretinoin Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alitretinoin Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alitretinoin Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Alitretinoin Drugs Segment by Company

Eisai

Stiefel Laboratories

GlaxoSmithKline

Ligand Pharmaceuticals

Dr. Reddy's Laboratories

Amdipharm

Alitretinoin Drugs Segment by Type

Gel

Capsules

Alitretinoin Drugs Segment by Application

Chronic Hand Eczema

Kaposi's Sarcoma

Other

Alitretinoin Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Alitretinoin Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alitretinoin Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alitretinoin Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Alitretinoin Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alitretinoin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alitretinoin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alitretinoin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alitretinoin Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alitretinoin Drugs industry.

Chapter 3: Detailed analysis of Alitretinoin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alitretinoin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alitretinoin Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alitretinoin Drugs Industry Trends Table 2. Alitretinoin Drugs Industry Drivers Table 3. Alitretinoin Drugs Industry Opportunities and Challenges Table 4. Alitretinoin Drugs Industry Restraints Table 5. Global Alitretinoin Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alitretinoin Drugs Revenue Share by Company (2021-2026) Table 7. Global Alitretinoin Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Alitretinoin Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Alitretinoin Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Alitretinoin Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alitretinoin Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Alitretinoin Drugs Company, Product Type & Application Table 13. Global Alitretinoin Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alitretinoin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Gel Table 18. Significant Companies of Capsules Table 19. Global Alitretinoin Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Alitretinoin Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Alitretinoin Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Alitretinoin Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Alitretinoin Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Alitretinoin Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Alitretinoin Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Alitretinoin Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Alitretinoin Drugs Sales Value Share by Type (2021-2026) Table 28. Global Alitretinoin Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Chronic Hand Eczema Table 30. Significant Companies of Kaposi's Sarcoma Table 31. Significant Companies of Other Table 32. Global Alitretinoin Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Alitretinoin Drugs Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Alitretinoin Drugs Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Alitretinoin Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Alitretinoin Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Alitretinoin Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Alitretinoin Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Alitretinoin Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Alitretinoin Drugs Sales Value Share by Application (2021-2026) Table 41. Global Alitretinoin Drugs Sales Value Share by Application (2027-2032) Table 42. Global Alitretinoin Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Alitretinoin Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Alitretinoin Drugs Sales Market Share by Region (2021-2026) Table 45. Global Alitretinoin Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Alitretinoin Drugs Sales Market Share by Region (2027-2032) Table 47. Global Alitretinoin Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Alitretinoin Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Alitretinoin Drugs Sales Value Share by Region (2021-2026) Table 50. Global Alitretinoin Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Alitretinoin Drugs Sales Value Share by Region (2027-2032) Table 52. Global Alitretinoin Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Alitretinoin Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Alitretinoin Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Alitretinoin Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Alitretinoin Drugs Sales by Country (2021-2026) & (K Units) Table 57. Global Alitretinoin Drugs Sales Market Share by Country (2021-2026) Table 58. Global Alitretinoin Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Alitretinoin Drugs Sales Market Share by Country (2027-2032) Table 60. Global Alitretinoin Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Alitretinoin Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Alitretinoin Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Alitretinoin Drugs Sales Value Market Share by Country (2027-2032) Table 64. Eisai Company Information Table 65. Eisai Business Overview Table 66. Eisai Alitretinoin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Eisai Alitretinoin Drugs Product Portfolio Table 68. Eisai Recent Development Table 69. Stiefel Laboratories Company Information Table 70. Stiefel Laboratories Business Overview Table 71. Stiefel Laboratories Alitretinoin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Stiefel Laboratories Alitretinoin Drugs Product Portfolio Table 73. Stiefel Laboratories Recent Development Table 74. GlaxoSmithKline Company Information Table 75. GlaxoSmithKline Business Overview Table 76. GlaxoSmithKline Alitretinoin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. GlaxoSmithKline Alitretinoin Drugs Product Portfolio Table 78. GlaxoSmithKline Recent Development Table 79. Ligand Pharmaceuticals Company Information Table 80. Ligand Pharmaceuticals Business Overview Table 81. Ligand Pharmaceuticals Alitretinoin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Ligand Pharmaceuticals Alitretinoin Drugs Product Portfolio Table 83. Ligand Pharmaceuticals Recent Development Table 84. Dr. Reddy's Laboratories Company Information Table 85. Dr. Reddy's Laboratories Business Overview Table 86. Dr. Reddy's Laboratories Alitretinoin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Dr. Reddy's Laboratories Alitretinoin Drugs Product Portfolio Table 88. Dr. Reddy's Laboratories Recent Development Table 89. Amdipharm Company Information Table 90. Amdipharm Business Overview Table 91. Amdipharm Alitretinoin Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Amdipharm Alitretinoin Drugs Product Portfolio Table 93. Amdipharm Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Alitretinoin Drugs Distributors List Table 97. Alitretinoin Drugs Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Alitretinoin Drugs Product Image Figure 2. Global Alitretinoin Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alitretinoin Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alitretinoin Drugs Sales (2021-2032) & (K Units) Figure 5. Global Alitretinoin Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Alitretinoin Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Gel Image Figure 10. Capsules Image Figure 11. Global Alitretinoin Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Alitretinoin Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Alitretinoin Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Alitretinoin Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Alitretinoin Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Alitretinoin Drugs Sales Value Share by Type (2021-2032) Figure 17. Chronic Hand Eczema Image Figure 18. Kaposi's Sarcoma Image Figure 19. Other Image Figure 20. Global Alitretinoin Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Alitretinoin Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Alitretinoin Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Alitretinoin Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Alitretinoin Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Alitretinoin Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Alitretinoin Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Alitretinoin Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Alitretinoin Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Alitretinoin Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Alitretinoin Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Alitretinoin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Alitretinoin Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Alitretinoin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Alitretinoin Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Alitretinoin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Alitretinoin Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Alitretinoin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Alitretinoin Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Alitretinoin Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Alitretinoin Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Alitretinoin Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Alitretinoin Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Gel
  • Capsules
Applications
  • Chronic Hand Eczema
  • Kaposi's Sarcoma
  • Other
Companies covered
  • Eisai
  • Stiefel Laboratories
  • GlaxoSmithKline
  • Ligand Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Amdipharm

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alitretinoin Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Alitretinoin Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Alitretinoin Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alitretinoin Drugs Market Dynamics
  1. 2.1 Alitretinoin Drugs Industry Trends
  2. 2.2 Alitretinoin Drugs Industry Drivers
  3. 2.3 Alitretinoin Drugs Industry Opportunities and Challenges
  4. 2.4 Alitretinoin Drugs Industry Restraints
3 Alitretinoin Drugs Market by Company
  1. 3.1 Global Alitretinoin Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Alitretinoin Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Alitretinoin Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Alitretinoin Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Alitretinoin Drugs Company Ranking (2024-2026)
  6. 3.6 Global Alitretinoin Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Alitretinoin Drugs Company Product Type and Application
  8. 3.8 Global Alitretinoin Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alitretinoin Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alitretinoin Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alitretinoin Drugs Market by Type
  1. 4.1 Alitretinoin Drugs Type Introduction
  2. 4.1.1 Gel
  3. 4.1.2 Capsules
  4. 4.2 Global Alitretinoin Drugs Sales Volume by Type
  5. 4.2.1 Global Alitretinoin Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alitretinoin Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Alitretinoin Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Alitretinoin Drugs Sales Value by Type
  9. 4.3.1 Global Alitretinoin Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alitretinoin Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Alitretinoin Drugs Sales Value Share by Type (2021-2032)
5 Alitretinoin Drugs Market by Application
  1. 5.1 Alitretinoin Drugs Application Introduction
  2. 5.1.1 Chronic Hand Eczema
  3. 5.1.2 Kaposi's Sarcoma
  4. 5.1.3 Other
  5. 5.2 Global Alitretinoin Drugs Sales Volume by Application
  6. 5.2.1 Global Alitretinoin Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Alitretinoin Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Alitretinoin Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Alitretinoin Drugs Sales Value by Application
  10. 5.3.1 Global Alitretinoin Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Alitretinoin Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Alitretinoin Drugs Sales Value Share by Application (2021-2032)
6 Alitretinoin Drugs Regional Sales and Value Analysis
  1. 6.1 Global Alitretinoin Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alitretinoin Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Alitretinoin Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Alitretinoin Drugs Sales by Region (2027-2032)
  5. 6.3 Global Alitretinoin Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alitretinoin Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alitretinoin Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alitretinoin Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Alitretinoin Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alitretinoin Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Alitretinoin Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alitretinoin Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Alitretinoin Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alitretinoin Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alitretinoin Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alitretinoin Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Alitretinoin Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alitretinoin Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alitretinoin Drugs Sales Value Share by Country, 2025 VS 2032
7 Alitretinoin Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Alitretinoin Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alitretinoin Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alitretinoin Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Alitretinoin Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Alitretinoin Drugs Sales by Country (2027-2032)
  6. 7.4 Global Alitretinoin Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alitretinoin Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alitretinoin Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alitretinoin Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alitretinoin Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alitretinoin Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai
  2. 8.1.1 Eisai Company Information
  3. 8.1.2 Eisai Business Overview
  4. 8.1.3 Eisai Alitretinoin Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Alitretinoin Drugs Product Portfolio
  6. 8.1.5 Eisai Recent Developments
  7. 8.2 Stiefel Laboratories
  8. 8.2.1 Stiefel Laboratories Company Information
  9. 8.2.2 Stiefel Laboratories Business Overview
  10. 8.2.3 Stiefel Laboratories Alitretinoin Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Stiefel Laboratories Alitretinoin Drugs Product Portfolio
  12. 8.2.5 Stiefel Laboratories Recent Developments
  13. 8.3 GlaxoSmithKline
  14. 8.3.1 GlaxoSmithKline Company Information
  15. 8.3.2 GlaxoSmithKline Business Overview
  16. 8.3.3 GlaxoSmithKline Alitretinoin Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 GlaxoSmithKline Alitretinoin Drugs Product Portfolio
  18. 8.3.5 GlaxoSmithKline Recent Developments
  19. 8.4 Ligand Pharmaceuticals
  20. 8.4.1 Ligand Pharmaceuticals Company Information
  21. 8.4.2 Ligand Pharmaceuticals Business Overview
  22. 8.4.3 Ligand Pharmaceuticals Alitretinoin Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ligand Pharmaceuticals Alitretinoin Drugs Product Portfolio
  24. 8.4.5 Ligand Pharmaceuticals Recent Developments
  25. 8.5 Dr. Reddy's Laboratories
  26. 8.5.1 Dr. Reddy's Laboratories Company Information
  27. 8.5.2 Dr. Reddy's Laboratories Business Overview
  28. 8.5.3 Dr. Reddy's Laboratories Alitretinoin Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy's Laboratories Alitretinoin Drugs Product Portfolio
  30. 8.5.5 Dr. Reddy's Laboratories Recent Developments
  31. 8.6 Amdipharm
  32. 8.6.1 Amdipharm Company Information
  33. 8.6.2 Amdipharm Business Overview
  34. 8.6.3 Amdipharm Alitretinoin Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Amdipharm Alitretinoin Drugs Product Portfolio
  36. 8.6.5 Amdipharm Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alitretinoin Drugs Value Chain Analysis
  2. 9.1.1 Alitretinoin Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alitretinoin Drugs Sales Mode & Process
  6. 9.2 Alitretinoin Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alitretinoin Drugs Distributors
  9. 9.2.3 Alitretinoin Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst